ScholarIQanswers from OpenAlex

Estimating the current and future prevalence of life-limiting conditions in children in England

PaperCitations, authors & open-access status

Estimating the current and future prevalence of life-limiting conditions in children in England is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Estimating the current and future prevalence of life-limiting conditions in children in England have?

ScholarIQcitation count

Estimating the current and future prevalence of life-limiting conditions in children in England has 202 citations in the OpenAlex counts ScholarIQ stores.

When was Estimating the current and future prevalence of life-limiting conditions in children in England published?

ScholarIQyear

Estimating the current and future prevalence of life-limiting conditions in children in England has 2020 year in the ScholarIQ index.

What is the open-access status of Estimating the current and future prevalence of life-limiting conditions in children in England?

ScholarIQoa status

Estimating the current and future prevalence of life-limiting conditions in children in England has hybrid oa status in the ScholarIQ index.

What is the DOI of Estimating the current and future prevalence of life-limiting conditions in children in England?

ScholarIQdoi

The DOI for Estimating the current and future prevalence of life-limiting conditions in children in England is on the source record.

What is the PMID of Estimating the current and future prevalence of life-limiting conditions in children in England?

ScholarIQpmid

The PMID for Estimating the current and future prevalence of life-limiting conditions in children in England is on the source record.

What is the OpenAlex record for Estimating the current and future prevalence of life-limiting conditions in children in England?

ScholarIQopenalex

The OpenAlex for Estimating the current and future prevalence of life-limiting conditions in children in England is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial